Skip to main content

Advertisement

SpringerLink
Log in

Cerebral vasospasm in subarachnoid hemorrhage

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

The treatment of vasospasm after subarachnoid hemorrhage remains a formidable challenge. The prompt recognition of this complication is essential to prevent ischemic damage. Initial orders should include adequate fluid and sodium supplementation to avoid volume depletion. Prophylactic hypervolemia is not effective in reducing the incidence of vasospasm and may be deleterious. Oral nimodipine (60 mg every 4 hours for 21 days) should be started on admission because it protects against delayed ischemic damage. Increasing blood flow velocities on serial transcranial Doppler studies are reliable indicators of early development of vasospasm. When symptomatic vasospasm occurs, hemodynamic augmentation therapy should be instituted. Crystalloids and colloids may be used to promote hypervolemia. Colloids may provide additional benefit by producing hemodilution. However, the rheological benefits of hemodilution may be offset by reduced oxygen carrying capacity when hematocrit drops below 28%. Hypertension may be induced by administering inotropic drugs and, in certain cases, cardiac output optimization using dobutamine also is necessary. When aggressive medical therapy fails to reverse ischemic deficits, prompt endovascular intervention is indicated. Focal vasospasm of larger vessels may be effectively treated with angioplasty and the benefits of this procedure are durable. Diffuse vasospasm involving smaller arterial branches may be treated with intra-arterial infusion of vasodilators, such as papaverine, verapamil, or nicardipine. Unfortunately, these dilatory effects tend to be short-lasting. In refractory cases, hypothermia may be considered, although value of this strategy remains largely unexplored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. van Gijn J, Rinkel GJ: Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001, 124:249–78. This is an excellent clinical review on subarachnoid hemorrhage. The discussion on treatment vasospasm is accurate, but limited.

    Article  PubMed  Google Scholar 

  2. Kivisaari RP, Salonen O, Servo A, et al.: MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study. AJNR Am J Neuroradiol 2001, 22:1143–1148.

    PubMed  CAS  Google Scholar 

  3. Hansen-Schwartz J: Cerebral vasospasm. A consideration of the various cellular mechanisms involved in the pathophysiology. Neurocritical Care 2004, 2:235–246. This is a detailed review on the current concepts underlying the pathophysiology of vasospasm.

    Article  Google Scholar 

  4. Kassell NF, Torner JC, Jane JA, et al.: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 1990, 73:37–47. This seminal multicenter trial involving more than 3500 patients contributed to the adoption of the current standard practice of early aneurysm surgery.

    PubMed  CAS  Google Scholar 

  5. Ross N, Hutchinson PJ, Seeley H, Kirkpatrick PJ: Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study. J Neurol Neurosurg Psychiatry 2002, 72:480–4.

    PubMed  CAS  Google Scholar 

  6. Whitfield PC, Kirkpatrick PJ: Timing of surgery for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2001, (2):CD001697.

  7. Brilstra EH, Rinkel GJ, Algra A, van Gijn J: Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000, 55:1656–60.

    PubMed  CAS  Google Scholar 

  8. Aiyagari V, Cross DT 3rd, Deibert E, et al.: Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage. Stroke 2001, 32:1994–7.

    PubMed  CAS  Google Scholar 

  9. Rabinstein AA, Pichelmann MA, Friedman JA, et al.: Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003, 98:319–25.

    PubMed  Google Scholar 

  10. Maroon JC, Nelson PB: Hypovolemia in patients with subarachnoid hemorrhage: therapeutic implications. Neurosurgery 1979, 4:223–6.

    Article  PubMed  CAS  Google Scholar 

  11. Wijdicks EF, Vermeulen M, ten Haaf JA, et al.: Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985, 18:211–6.

    Article  PubMed  CAS  Google Scholar 

  12. Berendes E, Walter M, Cullen P, et al.: Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997, 349:245–9.

    Article  PubMed  CAS  Google Scholar 

  13. Roos Y, Rinkel G, Vermeulen M, Algra A, van Gijn J: Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke 2003, 34:2308–9. This systematic review on all trials testing antifibrinolytic agents in subarachnoid hemorrhage. It concludes that the use of these drugs cannot be recommended since the increased risk of ischemic damage offsets the benefit on rebleeding.

    Article  PubMed  Google Scholar 

  14. Rabinstein AA, Friedman JA, Weigand SD, et al.: Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004, 35:1862–1866.

    Article  PubMed  Google Scholar 

  15. Aaslid R, Huber P, Nornes H: Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984, 60:37–41.

    Article  PubMed  CAS  Google Scholar 

  16. Suarez JI, Qureshi AI, Yahia AB, et al.: Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002, 30:1348–1355.

    Article  PubMed  Google Scholar 

  17. Lindegaard KF, Nornes H, Bakke SJ, et al.: Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989, 100:12–24.

    Article  CAS  Google Scholar 

  18. Sloan MA, Alexandrov AV, Tegeler CH, et al.: Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004, 62:1468–1481. This study is a must-read for clinicians involved in the interpretation of transcranial Doppler studies.

    PubMed  CAS  Google Scholar 

  19. Hadeishi H, Suzuki A, Yasui N, et al.: Diffusionweighted magnetic resonance imaging in patients with subarachnoid hemorrhage. Neurosurgery 2002, 50:741–747.

    Article  PubMed  Google Scholar 

  20. Shimoda M, Takeuchi M, Tominaga J, et al.: Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery 2001, 49:1341–1348.

    Article  PubMed  CAS  Google Scholar 

  21. Romano JG, Forteza AM, Concha M, et al.: Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 2002, 50:1026–1030.

    Article  PubMed  Google Scholar 

  22. Kreiter KT, Copeland D, Bernardini GL, et al.: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 2002, 33:200–208.

    Article  PubMed  Google Scholar 

  23. Mayer SA, Solomon RA, Fink ME, et al.: Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery 1998, 42:759–767. This randomized study shows evidence that supplemental albumin prevents sodium and fluid losses in patients with subarachnoid hemorrhage. This may result in a lower incidence of complications related to iatrogenic fluid overload.

    Article  PubMed  CAS  Google Scholar 

  24. Lennihan L, Mayer SA, Fink ME, et al.: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000, 31:383–391. This landmark randomized study showing that prophylactic hypervolemia does not increase cerebral blood flow (as measured by the method of 133Xe clearance) compared with therapy aimed at maintaining normovolemia.

    PubMed  CAS  Google Scholar 

  25. Egge A, Waterloo K, Sjoholm H, et al.: Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001, 49:593–605. This study confirms that prophylactic hemodynamic augmentation is not more effective in preventing clinical or ultrasonographic vasospasm than more conservative normovolemic therapy. Additionally, cost and complications were higher in the hypervolemic group.

    Article  PubMed  CAS  Google Scholar 

  26. Mayberg MR, Batjer HH, Dacey R, et al.: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994, 25:2315–2328. These guidelines are somewhat dated, but remain clinically useful.

    PubMed  CAS  Google Scholar 

  27. Feigin VL, Rinkel GJ, Algra A, et al.: Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998, 50:876–883. This excellent and well-balanced summary of the trials that tested the use of calcium antagonists in subarachnoid hemorrhage, including those that support the recommended use of oral nimodipine.

    PubMed  CAS  Google Scholar 

  28. Haley Jr EC, Kassell NF, Torner JC: A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 1993, 78:548–553.

    PubMed  Google Scholar 

  29. Heros RC, Korosue K: Hemodilution for cerebral ischemia. Stroke 1989, 20:423–427.

    PubMed  CAS  Google Scholar 

  30. Mori K, Arai H, Nakajima K, et al.: Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1995, 26:1620–1626.

    PubMed  CAS  Google Scholar 

  31. Ekelund A, Reinstrup P, Ryding E, et al.: Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2002, 144:703–712.

    Article  CAS  Google Scholar 

  32. Treggiari MM, Walder B, Suter PM, Romand JA: Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003, 98:978–84. This is a critical review of the literature on triple H therapy. The carefully stated conclusions appropriately point to the need for randomized, controlled trials instead of negating the usefulness of this treatment strategy.

    PubMed  Google Scholar 

  33. Origitano TC, Wascher TM, Reichman OH, Anderson DE: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery 1990, 27:729–739.

    Article  PubMed  CAS  Google Scholar 

  34. Otsubo H, Takemae T, Inoue T, et al.: Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 1990, 103:18–26.

    Article  CAS  Google Scholar 

  35. Levy ML, Rabb CH, Zelman V, Giannotta SL: Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993, 79:494–499.

    PubMed  CAS  Google Scholar 

  36. Sen J, Belli A, Albon H, et al.: Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003, 2:614–621.

    Article  PubMed  Google Scholar 

  37. Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE: Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 1999, 44:1113–1116.

    Article  PubMed  CAS  Google Scholar 

  38. Eskridge JM, McAuliffe W, Song JK, et al.: Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998, 42:510–516. This is a descriptive study on the good results obtained by the authors using balloon angioplasty to treat refractory vasospasm.

    Article  PubMed  CAS  Google Scholar 

  39. Bejjani GK, Bank WO, Olan WJ, et al.: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998, 42:979–986.

    Article  PubMed  CAS  Google Scholar 

  40. Katoh H, Shima K, Shimizu A, et al.: Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999, 21:195–203.

    PubMed  CAS  Google Scholar 

  41. Elliott JP, Newell DW, Lam DJ, et al.: Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998, 88:277–284.

    PubMed  CAS  Google Scholar 

  42. Kaku Y, Yonekawa Y, Tsukahara T, et al.: Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992, 77:842–847.

    PubMed  CAS  Google Scholar 

  43. Milburn JM, Moran CJ, Cross DT, et al.: Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998, 88:38–42.

    Article  PubMed  CAS  Google Scholar 

  44. Feng L, Fitzsimmons BF, Young WL, et al.: Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002, 23:1284–1290.

    PubMed  Google Scholar 

  45. Biondi A, Ricciardi GK, Puybasset L, et al.: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004, 25:1067–1076.

    PubMed  Google Scholar 

  46. Badjatia N, Topcuoglu MA, Pryor JC, et al.: Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004, 25:819–826.

    PubMed  Google Scholar 

  47. Rosenwasser RH, Armonda RA, Thomas JE, et al.: Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999, 44:975–979.

    Article  PubMed  CAS  Google Scholar 

  48. Hop JW, Rinkel GJ, Algra A, et al.: Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 2000, 54:872–878.

    PubMed  CAS  Google Scholar 

  49. Wurm G, Tomancok B, Nussbaumer K, et al.: Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 2004, 106:97–103.

    Article  PubMed  Google Scholar 

  50. Siironen J, Juvela S, Varis J, et al.: No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebocontrolled clinical trial. J Neurosurg 2003, 99:953–959.

    PubMed  CAS  Google Scholar 

  51. Findlay JM, Kassell NF, Weir BK, et al.: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995, 37:168–176.

    Article  PubMed  CAS  Google Scholar 

  52. Gasser S, Khan N, Yonekawa Y, et al.: Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage: feasibility and intensive care complications. J Neurosurg Anesthesiol 2003, 15:240–248.

    Article  PubMed  Google Scholar 

  53. Finfer SR, Ferch R, Morgan MK: Barbiturate coma for severe, refractory vasospasm following subarachnoid haemorrhage. Intensive Care Med 1999, 25:406–409.

    Article  PubMed  CAS  Google Scholar 

  54. Badjatia N, O’Donnell J, Baker JR, et al.: Achieving normothermia in patients with febrile subarachnoid hemorrhage. Feasibility and safety of a novel intravascular cooling catheter. Neurocritical Care 2004, 1:145–156.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Miami School of Medicine, 33124, Miami, FL, USA

    Alejandro A. Rabinstein MD

Authors
  1. Alejandro A. Rabinstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eelco F. M. Wijdicks MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rabinstein, A.A., Wijdicks, E.F.M. Cerebral vasospasm in subarachnoid hemorrhage. Curr Treat Options Neurol 7, 99–107 (2005). https://doi.org/10.1007/s11940-005-0019-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-005-0019-x

Keywords

Search

Navigation